Read More AAD 2026: The Compounding Conversations Every Dermatology Prescriber Should Be Having As thousands of dermatologists, residents, and prescribers gather in Denver for the American Academy of Dermatologys 2026 Annual Meeting, the scientific sessions will cover the usual spectrum: biologics for atopic dermatitis, checkpoint inhibitor dermatology, advances in melanoma imaging, new approaches to acne scarring
DIM, short for diindolylmethane, is a hormone balancer that can be beneficial for breast, uterine, cervical, and prostate health
DrMR: Sorry
In real-world practice, the stacking conversation often blurs three very different categories: FDA-approved peptide drugs (e.g., tesamorelin for HIV-associated lipodystrophymore on this below) (FDA Access Data) Non-approved peptides sometimes discussed in compounding/wellness circles (e.g., AOD-9604, BPC-157, CJC-1295, ipamorelin) Unregulated research use only products sold online (which often have the worst quality and highest risk) That distinction matters because safety isnt just about pharmacologyits also about purity, stability, sterility, and labeling accuracy
If you dont have easy access to a doctor, Doctronic.ai offers quick, affordable telehealth visits with licensed physicians who can provide guidance
What are the tolerability profiles of each